NEW YORK MEDICAL COLLEGE TO HOST THE ML4 FOUNDATION INTERNATIONAL SYMPOSIUM
Valhalla, N.Y., June 17, 2013—New York Medical College will host the Mucolipidosis IV Foundation (ML4) International Symposium on June 18 and 19 in the Center for Interactive Learning, which is located in the School of Health Sciences and Practice on the Valhalla campus. Renowned researchers from the fields of genetics, biology, chemistry, and neurology will discuss mutation and clinical overview, protein function, disease pathogenesis, potential therapeutic avenues, translational research and NIH resources for rare disease research. Edward C. Halperin, M.D., M.A., chancellor for health affairs and chief executive officer, will deliver opening remarks. The event is by invitation only.
ML4, which was first identified in 1974 in Israel and dominantly impacts Jews of Ashkenazi descent, is a genetic disease causing mental retardation, retinal degeneration, and limited lifespan. The ML4 Foundation funds, promotes, and supports medical research dedicated to developing treatments and a cure. For more information please visit http://ml4.org/
Donna Moriarty, M.P.H. ’04
O: (914) 594-4536 | C: (914) 439-5989